Logo image of PMO

PUTNAM MUNICIPAL OPPOR (PMO) Stock Price, Quote, News and Overview

NYSE:PMO - New York Stock Exchange, Inc. - US7469221037 - Currency: USD

10.67  +0.01 (+0.09%)

Fundamental Rating

2

PMO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. PMO may be in some trouble as it scores bad on both profitability and health. PMO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year PMO was profitable.
The reported net income has been mixed in the past 5 years: PMO reported negative net income in multiple years.
PMO had a positive operating cash flow in 4 of the past 5 years.
PMO Yearly Net Income VS EBIT VS OCF VS FCFPMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

1.2 Ratios

The 3 year average ROIC (2.14%) for PMO is below the current ROIC(2.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.49%
ROE 1.59%
ROIC 2.87%
ROA(3y)1.04%
ROA(5y)1.38%
ROE(3y)0.87%
ROE(5y)1.37%
ROIC(3y)2.14%
ROIC(5y)2.29%
PMO Yearly ROA, ROE, ROICPMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

In the last couple of years the Profit Margin of PMO has declined.
PMO's Operating Margin has been stable in the last couple of years.
PMO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 80.66%
PM (TTM) 34.12%
GM 79.44%
OM growth 3Y-0.54%
OM growth 5Y-0.65%
PM growth 3YN/A
PM growth 5Y-14.3%
GM growth 3Y-0.91%
GM growth 5Y-0.84%
PMO Yearly Profit, Operating, Gross MarginsPMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, PMO has less shares outstanding
Compared to 5 years ago, PMO has less shares outstanding
Compared to 1 year ago, PMO has an improved debt to assets ratio.
PMO Yearly Shares OutstandingPMO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
PMO Yearly Total Debt VS Total AssetsPMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

PMO has an Altman-Z score of 6.10. This indicates that PMO is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.04 indicates that PMO is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 6.1
ROIC/WACCN/A
WACCN/A
PMO Yearly LT Debt VS Equity VS FCFPMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

PMO has a Current Ratio of 0.89. This is a bad value and indicates that PMO is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.89 indicates that PMO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.89
PMO Yearly Current Assets VS Current LiabilitesPMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 105.88% over the past year.
The earnings per share for PMO have been decreasing by -18.34% on average. This is quite bad
The Revenue has been growing slightly by 5.62% in the past year.
Measured over the past years, PMO shows a decrease in Revenue. The Revenue has been decreasing by -6.38% on average per year.
EPS 1Y (TTM)105.88%
EPS 3YN/A
EPS 5Y-18.34%
EPS Q2Q%0.88%
Revenue 1Y (TTM)5.62%
Revenue growth 3Y-2.68%
Revenue growth 5Y-6.38%
Sales Q2Q%1.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PMO Yearly Revenue VS EstimatesPMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
PMO Yearly EPS VS EstimatesPMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 62.76, the valuation of PMO can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 29.62, PMO is valued quite expensively.
Industry RankSector Rank
PE 62.76
Fwd PE N/A
PMO Price Earnings VS Forward Price EarningsPMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PMO Per share dataPMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

PMO has a Yearly Dividend Yield of 3.60%.
PMO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 3.6%

5.2 History

PMO has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PMO Yearly Dividends per sharePMO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

PMO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-147.69%
EPS Next 2YN/A
EPS Next 3YN/A
PMO Yearly Income VS Free CF VS DividendPMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

More info and screens

PUTNAM MUNICIPAL OPPOR

NYSE:PMO (2/24/2025, 3:42:06 PM)

10.67

+0.01 (+0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners24.46%
Inst Owner Change-73.61%
Ins Owners0.13%
Ins Owner Change0%
Market Cap315.83M
Analysts0
Price TargetN/A
Short Float %0.3%
Short Ratio0.84
Dividend
Industry RankSector Rank
Dividend Yield 3.6%
Yearly Dividend0.64
Dividend Growth(5Y)N/A
DP-147.69%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-24 2025-02-24 (0.035)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 62.76
Fwd PE N/A
P/S 14.7
P/FCF N/A
P/OCF N/A
P/B 0.69
P/tB 0.69
EV/EBITDA N/A
EPS(TTM)0.17
EY1.59%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.73
BVpS15.55
TBVpS15.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.49%
ROE 1.59%
ROCE 3.63%
ROIC 2.87%
ROICexc 2.87%
ROICexgc 2.87%
OM 80.66%
PM (TTM) 34.12%
GM 79.44%
FCFM N/A
ROA(3y)1.04%
ROA(5y)1.38%
ROE(3y)0.87%
ROE(5y)1.37%
ROIC(3y)2.14%
ROIC(5y)2.29%
ROICexc(3y)2.14%
ROICexc(5y)2.29%
ROICexgc(3y)2.14%
ROICexgc(5y)2.29%
ROCE(3y)2.71%
ROCE(5y)2.89%
ROICexcg growth 3Y0.91%
ROICexcg growth 5Y-3.48%
ROICexc growth 3Y1%
ROICexc growth 5Y-3.48%
OM growth 3Y-0.54%
OM growth 5Y-0.65%
PM growth 3YN/A
PM growth 5Y-14.3%
GM growth 3Y-0.91%
GM growth 5Y-0.84%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.89
Altman-Z 6.1
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.88%
EPS 3YN/A
EPS 5Y-18.34%
EPS Q2Q%0.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.62%
Revenue growth 3Y-2.68%
Revenue growth 5Y-6.38%
Sales Q2Q%1.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.86%
EBIT growth 3Y-3.21%
EBIT growth 5Y-6.99%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y149.84%
FCF growth 3YN/A
FCF growth 5Y-6.32%
OCF growth 1Y149.84%
OCF growth 3YN/A
OCF growth 5Y-6.32%